Showing results (1171-1180 of 5,484) with videos related to
Sort By:
Pageof 549
Pancreas|May 18, 2018
A Therapeutic Strategy for Resectable Pancreatic Cancer Based on Risk Factors of Early RecurrenceHiroshi Kurahara, Kosei Maemura, Yuko Mataki, et al.Pancreas|April 19, 2002
Processing of the major pancreatic zymogen granule membrane protein, GP2Benjamin A Fritz, Clinton S Poppel, Matthew W Fei, et al.Pancreas|July 21, 2018
Pancreatic Fat Content Detected by Computed Tomography and Its Significant Relationship With Intraductal Papillary Mucinous NeoplasmKazuhiro Kashiwagi, Takashi Seino, Seiichirou Fukuhara, et al.Pancreas|July 24, 2018
Survival and Prognostic Factors in Patients With Solid Pseudopapillary Neoplasms of the PancreasBrandon M Huffman, Gustavo Westin, Samer Alsidawi, et al.Pancreas|July 26, 2018
Early Predictors of Abdominal Hemorrhage Among Critically Ill Patients With Pancreatitis: A Prospective Cohort StudyEduardo Labarca, Felix Zubia, Enrique Maraví-Poma, et al.Pancreas|July 6, 2018
Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus PatientsSeungho Lee, Ho Kyoung Hwang, Chang Moo Kang, et al.Pancreas|July 6, 2018
A Novel Approach for Therapeutic Delivery to the Rodent Pancreas Via Its Arterial Blood SupplyJeff Choi, Jing Wang, Gang Ren, et al.Pancreas|December 13, 2005
Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic dataMario Airoldi, Luigi Cattel, Roberto Passera, et al.Pancreas|December 13, 2005
A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: is this a strategy still worth pursuing?Alison J Clayton, Abdul W Mansoor, Eileen T Jones, et al.Pancreas|December 13, 2005
Conservative management of acute pancreatitis: complications and outcome in a community-based hospitalClaus Niederau, Jörg HippenstielPageof 549